Grants for For profit organizations other than small businesses - Health

This grant provides financial support to organizations dedicated to improving the rights, health, education, and empowerment of girls both locally in the San Francisco Bay Area and internationally.

This grant provides funding for researchers and organizations to develop innovative treatments and interventions for ataxia telangiectasia, focusing on projects with a clear path to clinical application.

This grant provides financial support to various organizations and initiatives focused on improving the physical, social, and economic well-being of the Painesville community and its surrounding areas.

This grant provides financial support for a variety of community projects in Miami County, focusing on education, health, arts, and more, with an emphasis on innovative initiatives that benefit underserved populations.

This funding opportunity supports 501(c)(3) organizations that improve the health and well-being of communities in Alabama.

This grant provides funding for non-profit organizations and researchers to conduct studies that address unmet medical needs and advance treatment in B. Braun's therapeutic areas of interest.

This funding opportunity supports various community projects in Starke County, Indiana, focusing on education, health, arts, and development, with grants available for organizations and schools in the area.

This grant provides funding to nonprofits and community initiatives in Vermont that aim to improve economic equity, education, health, and community leadership to help close the opportunity gap.

City of San Marcos Minority Business Stabilization Fund (Texas) - The City of San Marcos is offering minority entrepreneurs and small business owners within corporate city limits the opportunity to apply for the Minority Business Stabilization Fund Program. This one-time grant assistance program, funded through the American Rescue Plan Act (ARPA), provides direct aid to minority-owned businesses in San Marcos. Grant amounts range from $1,000 to $10,000 based on the number of full-time employees and can be used for eligible expenses such as physical improvements, equipment, e-commerce expansion costs, rent, payroll, and operating expenses. To be eligible, businesses must have been in operation in San Marcos for at least 12 months, employ 1 to 25 full-time employees, and be at least 51% unconditionally owned by a socially disadvantaged individual. Only one grant may be awarded per business with multiple locations in San Marcos. For more information and to apply, visit City of San Marcos website.

The BlueAngel Community Health Grant program at Blue Cross & Blue Shield of Rhode Island aims to fund organizations and programs that will result in more Rhode Islanders being able to afford safe, healthy, and stable housing. The program seeks to increase awareness about safe, affordable housing as a shared public concern and highlight solutions to support access to safe and affordable housing. The grant is open to Rhode Island nonprofit agencies that have qualified for exemption under Section 501(c)(3) of the IRS Code or are public instrumentalities. Funding amounts historically range from $25,000 per year to $75,000 per year. Applicants are invited to submit a Letter of Intent (LOI), which will be reviewed by a BCBSRI LOI Review Subcommittee. Selected agencies will then be invited to submit full proposals for funding. Site visits will be conducted by Community Relations staff with each of the finalist organizations. The 2024 grant application cycle is closed, and funding awards begin in January 2024. For more information or questions, potential applicants can email [email protected].

The purpose of this NIDCD initiative is to encourage research in the development, characterization, and reproducibility/reliability of human auditory and vestibular organoids.Applications investigating animal organoids are allowable but only if accompanying comparative or other integrated companion studies with human organoids. Singular animal organoid studies alone are not responsive to this funding opportunity. This funding opportunity encourages innovative, reproducible, and novel methodologies and technologies that will drive the reproducibility and holistic longevity of hearing/balance sensory organoids as model systems. The development of novel tools to deliver genes, proteins, molecules, and synthetics that might lead to the successful expansion and longer-term survivability of organoid populations in a stable, reliable, and reproducible manner is highly encouraged. Subsequent characterization of the organoid platforms must be shown to mimic and recapitulate the native correlative biological function. Applications that provide approaches that remove current barriers and lessen challenges to improve current reproducibility and stability are highly encouraged. Applications that have breakthrough approaches and technologies using human auditory/vestibular organoids are highly encouraged.

This funding opportunity supports U.S. institutions in developing comprehensive training programs for graduate students in basic biomedical sciences, with a focus on fostering diversity and preparing them for careers in health-related research.

The National Institute on Drug Abuseintends to promote a new initiative by publishing a notice of funding opportunity (NOFO) to seek applications for research hubs to participate in Phase II of the Justice Community Overdose Innovation Network (JCOIN). This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Fall 2025with an expected application due date in Winter 2025. Details of the planned NOFO are provided below.

The NINDSintends to reissuePAR-23-027 to solicit applications for basic research projects on chemical warfare agents, toxic industrial chemicals, and pesticides that have primary or secondary effects on the nervous system. Chemical threats are toxic compounds that could be used in a terrorist attack or accidentally released from industrial production, storage, or shipping. Projects supported by this NOFO are expected to generate data that elucidate mechanisms of toxicity of these agents, possible new manifestations of toxic exposures, and potential new targets for therapeutic development. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Winter 2024 with an expected application due date in Spring 2024. This NOFO will utilize the R01 activity code. Details of the planned NOFO are provided below.

The purpose of this Notice of Funding Opportunity (NOFO) is to support proof-of-concept feasibility trials guided by the NIH Music-based Interventions (MBI) Toolkit for research on brain disorders of aging. These early phase clinical trials will generate evidence supporting the validity of the NIH MBI Toolkits guiding principles as well as the necessary pilot data to design a subsequent clinical efficacy or effectiveness study (or pragmatic clinical trial) using music-based interventions in the context of brain disorders of aging, including but not limited to Alzheimers disease and Alzheimers disease-related dementias, Parkinsons disease, and stroke. The data collected should address gaps in scientific knowledge in order to facilitate development of a competitive large-scale clinical trial.

This funding opportunity supports research projects that improve medical and human performance capabilities for military personnel, focusing on innovative solutions for Special Operations Forces in challenging environments.

The National Institute of Mental Health (NIMH) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications encouraging foundational research projects that seek to refine and test valid methods for characterizing preteen suicide risk and protective factors across multiple domains, and for operationalizing suicide thoughts and behavior (STBs) and nonsuicidal self-injury (NSSI) among preteen youth (ages 8-12). An emphasis is placed on the inclusion of sub-populations of youth that experience health disparities and may have been underrepresented in prior youth suicide research. Studies may focus on developing new or adapting developmentally and culturally appropriate methods for assessing and characterizing risk and protective factors, examining the acceptability and utility of existing assessment methods, evaluating the relevance of risk and protective factors for diverse preteen youth and their families, modeling risk-factor trajectories, and refining sampling strategies. The research projects funded through this announcement will participate in a research consortium with other R01 recipients. In addition, each research site will work with the Data Coordinating Center (DCC) site (supported by a companion announcement) to share and analyze data, recommend candidate measures that will be included as common data elements in future research and practice contexts,and identify optimal approaches for sampling individuals from underrepresented backgrounds. This Notice of Intent to Publish (NOITP) is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects, and to consult with NIH in order to submit responsive applications. The NOFO is expected to be published in Summer 2023, with an expected application due date in Fall 2023. This NOFO will utilize the R01 activity code. Details of the planned NOFO are provided below.

The purpose of this program is to support Community-Led Monitoring of HIV services at selected health service sites to promote improvements in the HIV response under the Presidents Emergency Plan for AIDS Relief (PEPFAR).Community-led monitoring (CLM) is a technique initiated and implemented by local community-based organizations and other civil society groups, networks of key populations (KP), people living with HIV (PLHIV), and other affected groups or other community entities that gathers quantitative and qualitative data about HIV services. The focus is on getting input from recipients of HIV services, especially key populations and underserved groups, in a routine and systematic manner that will translate into action and change. CLM is central to PEPFAR’s client-centered approach because it helps puts communities, their needs, and their voices at the center of the HIV response. Why does PEPFAR support Community-Led Monitoring? CLM conducted by local civil society organizations helps PEPFAR programs and health institutions diagnose and pinpoint persistent problems, challenges, and barriers related to HIV service access, uptake, and retention at the community and facility level. CLM aims to improve HIV service delivery and client outcomes by identifying data-driven solutions to overcome barriers and ensure beneficiaries receive optimal client-centered HIV services in a manner that is productive, collaborative, respectful, and solutions-oriented. Who does PEPFAR fund for CLM? PEPFAR-supported CLM is conducted objectively by independent, local community organizations. PEPFAR implementing partners who currently work on service delivery at the site level are not eligible for CLM funding, even if they will sub-grant to a local civil society organization. What is monitored and how? Systematic and routine, with follow up and continuous improvement. Tailored to the needs identified by local communities, with communities directly determining the scope. Allow for community and host country government development of the specific metrics, measures, or tools to be used for CLM. Metrics or measures should be tailored to a given context and address the specific needs and concerns of community members. Triangulated with, but not duplicative of, other PEPFAR data streams. Community-led monitoring data should reflect an ‘added value’ and not duplicate collection of routine data already available to PEPFAR. ‘Added value’ monitoring data includes: information from beneficiaries about their experience with the health facility, information about barriers and enablers to access and retention in services, etc. Productive, collaborative, respectful, and solutions-oriented. Action-oriented with an associated follow-up process with the health facility that is overseen by U.S. government staff, committed to corrective public health action, and involves community advocacy to improve service outcomes

The U.S. Agency for International Development Mission in Haiti (USAID/Haiti) is seeking information about potential partners, in particular local entities, for an upcoming activity in Haiti. Interested parties should submit their responses using Attachment A electronically to [email protected]; [email protected]; and [email protected] with the subject title OVC/AGYW in Haiti Sources Sought Notice (SSN) 72052123RFI00002 no later than August 1st, 2023, by 16:00 Haiti time. A separate capabilities statement may be included as long as at least the same information as in Attachment A is provided.You may receive an electronic confirmation acknowledging receipt of your response but will not receive individualized feedback. We may reach out to individual respondents for further clarifications. Local organizations (nonprofit and for-profit entities) registered with the Government of Haiti are strongly encouraged to respond.This is not a solicitation and should not be construed as a commitment by the United States Government to issue any solicitation or ultimately award based on this SSN or to pay for any cost incurred in the preparation and submission in responses to this SSN. Responding to this SSN will not give an entity any advantage in any subsequent procurement. Responses will be used for internal purposes and will be held confidentially. However, responders are advised to not submit proprietary information.Thank you for your interest in USAID programs in Haiti.

The National Center for Advancing Translational Sciences (NCATS) intends to publish aNotice of Funding Opportunity (NOFO) to solicit applications for research to advance the diagnosis, management, and treatment of rare diseases. Each Rare Diseases Clinical Research Consortium (RDCRC) will promote highly collaborative, multi-site, patient-centric, translational, and clinical research. It is strongly encouraged that the RDCRC study outcome measures include those that address unmet clinical trial readiness needs that will move the field of research forward from its current state. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in winter 2024, with an expected application due date in summer 2024. This NOFO will utilize the U54 activity code, which supports specialized centers through multi-project cooperative agreement awards to support research activities with substantial involvement from NIH program staff. Details of the planned NOFO are provided below.